(1C) 3.2: In children with CKD (including those treated with chronic dialysis or kidney transplantation), we suggest annual follow-up measurement of fasting lipid levels. (Not Graded) CHAPTER 4: PHARMACOLOGICAL CHOLESTEROL- LOWERING TREATMENT IN CHILDREN 4.1: In children less than 18 years of age with CKD (including those treated with chronic dialysis or kidney transplantation), we suggest that statins or statin/ezetimibe combination not be initiated. (2C) CHAPTER 5: TRIGLYCERIDE-LOWERING TREATMENT IN ADULTS 5.1: In adults with CKD (including those treated with chronic dialysis or kidney transplantation) and hypertriglyceridemia, we suggest that therapeutic lifestyle changes be advised. (2D) CHAPTER 6: TRIGLYCERIDE-LOWERING TREATMENT IN CHILDREN 6.1: In children with CKD (including those treated with chronic dialysis or kidney transplantation) and hypertrigly- ceridemia, we suggest that therapeutic lifestyle changes be C review